Soon we’ll not be supporting this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Angle plc (AGL) Ordinary 10p

Sell:118.00p Buy:120.00p 0 Change: 2.00p (1.65%)
Market closed Prices as at close on 17 September 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:118.00p
Buy:120.00p
Change: 2.00p (1.65%)
Market closed Prices as at close on 17 September 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:118.00p
Buy:120.00p
Change: 2.00p (1.65%)
Market closed Prices as at close on 17 September 2021 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

ANGLE plc is a holding company. The Company's principal activity is undertaken in relation to the commercialization of its Parsortix cell separation system, with deployment in non-invasive cancer diagnostics. The Company is a specialist medical diagnostic company, which offers products for cancer diagnostics and fetal health. Its Parsortix cell separation system uses a microfluidic technology in the form of a one-time use cassette to capture and then harvest circulating tumor cells (CTCs) from blood. The cassette captures CTCs based on their less deformable nature and larger size compared to other blood components. The resulting liquid biopsy (blood test) enables the detection and investigation of mutations in the patient's cancer for personalized cancer care. The harvested CTCs have a range of applications, including diagnosis, prognosis, mutational analysis and drug selection, drug development, assessment of treatment effectiveness and remission monitoring.

Contact details

Address:
The Surrey Research Park, 10 Nugent Road
GUILDFORD
GU2 7AF
United Kingdom
Telephone:
+44 (01483) 343434
Website:
https://www.angleplc.com/

Important dates

Future events
Interim results 30 September 2021 30/09/21
Past events
AGM 30 June 2021 30/06/21
Trading Announcement 18 June 2021 18/06/21
AGM 10 June 2021 10/06/21
Final results 29 April 2021 29/04/21
General meeting 13 November 2020 13/11/20
Interim results 29 October 2020 29/10/20

General stock information

EPIC:
AGL
ISIN:
GB0034330679
Market cap:
£279.47 million
Shares in issue:
234.85 million
Sector:
Pharmaceuticals & Biotechnology
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • Andrew Newland
    Chief Executive, Executive Director
  • Ian Griffiths
    Finance Director, Company Secretary, Executive Director

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.